Lupin Limited has informed the Exchange regarding a press release dated July 01, 2021, titled "Lupin Announces FDA Approval of Supplemental New Drug Application forSOLOSEC�� (secnidazole) for the Treatment of Trichomoniasis.".
Lupin Limited has informed the Exchange regarding a press release dated July 01, 2021, titled "Lupin Announces FDA Approval of Supplemental New Drug Application forSOLOSEC�� (secnidazole) for the Treatment of Trichomoniasis.".